Clinical Trial Update: OSI-906 and Irinotecan in Patients With Advanced Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial of OSI-906 in combination with irinotecan in advanced colorectal cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Irinotecan (Irinotecan)
• OSI-906 (OSI-906)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Colorectal Cancer | Phase 1 | Status: TERMINATED